AllTrials has changed the world
(Source: PharmaGossip)
Source: PharmaGossip - May 1, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
From Evidence-Based Medicine to Marketing-Based Medicine
Dr Peter Parry is an Australian child& adolescent psychiatrist who has researched the "Pediatric Bipolar Disorder" diagnosis emanating from the USA, a diagnosis completely at odds with his training and clinical experience in Australian child and adolescent mental health. As part of his research into the PBD phenomenon, he noticed hundreds of internal pharmaceutical industry documents publicly released from court cases against pharmaceutical firms by State and Federal Attorney Generals in the USA. These documents concurred with findings of the US Senate "Grassley Commission" into conflicts of interest between the p...
Source: PharmaGossip - May 1, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Ben Goldacre - Progress and Barriers on Clinical Trials Transparency
(Source: PharmaGossip)
Source: PharmaGossip - May 1, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
AllTrials has changed the world
(Source: PharmaGossip)
Source: PharmaGossip - April 30, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
From Evidence-Based Medicine to Marketing-Based Medicine
Dr Peter Parry is an Australian child & adolescent psychiatrist who has researched the "Pediatric Bipolar Disorder" diagnosis emanating from the USA, a diagnosis completely at odds with his training and clinical experience in Australian child and adolescent mental health. As part of his research into the PBD phenomenon, he noticed hundreds of internal pharmaceutical industry documents publicly released from court cases against pharmaceutical firms by State and Federal Attorney Generals in the USA. These documents concurred with findings of the US Senate "Grassley Commission" into conflicts of interest between the ...
Source: PharmaGossip - April 30, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Ben Goldacre - Progress and Barriers on Clinical Trials Transparency
(Source: PharmaGossip)
Source: PharmaGossip - April 30, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Psychiatrists With Ties to AstraZeneca Resign From Texas State Hospital
By ED SILVERMANBloomberg NewsTwo psychiatrists at a Texas state hospital have resigned after being told they would face disciplinary actions for accepting hundreds of thousands of dollars in speaking and consulting fees from AstraZeneca AZN +1.58% while also promoting one of its drugs to state officials, according to a spokeswoman for the Texas Department of State Health Services.The psychiatrists allegedly violated various department rules as a result of their relationship to the drug maker, which involved efforts to ensure the Seroquel XR antipsychotic would be placed on the state formulary&...
Source: PharmaGossip - April 22, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Psychiatrists With Ties to AstraZeneca Resign From Texas State Hospital
By ED SILVERMAN Bloomberg NewsTwo psychiatrists at a Texas state hospital have resigned after being told they would face disciplinary actions for accepting hundreds of thousands of dollars in speaking and consulting fees from AstraZeneca AZN +1.58% while also promoting one of its drugs to state officials, according to a spokeswoman for the Texas Department of State Health Services.The psychiatrists allegedly violated various department rules as a result of their relationship to the drug maker, which involved efforts to ensure the Seroquel XR antipsychotic would be placed on the state formular...
Source: PharmaGossip - April 21, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Yes!
WHO calls for increased transparency in medical researchNote for the media14 April 201514 APRIL | 2015 GENEVA - WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.“Our intention is to promote the sharing of scientific knowledge in order to advance public health,” said Dr. Marie-Paule Kieny, WHO Assistant Director General for Health Systems and Innovat...
Source: PharmaGossip - April 14, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Yes!
WHO calls for increased transparency in medical researchNote for the media14 April 201514 APRIL | 2015 GENEVA - WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result. The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.“Our intention is to promote the sharing of scientific knowledge in order to advance public health,” said Dr. Marie-Paule Kieny, WHO Assistant Director General for Health Systems and Innovat...
Source: PharmaGossip - April 13, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Read it and weep - then get angry!
The Deadly Corruption of Clinical TrialsUpdate (4/3/2015): After nearly 11 years of obfuscation and denial surrounding the tragic death of Dan Markingson, the University of Minnesota has suspended enrollment in psychiatric drug trials. This comes in response to a blistering report issued by the Minnesota State Legislative Auditor that cites "serious ethical issues" and vindicates much of the reporting in the story below. Read more from Carl Elliott about the fallout from the report here.IT'S NOT EASY TO WORK UP a good feeling about the institution that destroyed your life, which may be why Mary Weiss i...
Source: PharmaGossip - April 4, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Read it and weep - then get angry!
The Deadly Corruption of Clinical TrialsUpdate (4/3/2015): After nearly 11 years of obfuscation and denial surrounding the tragic death of Dan Markingson, the University of Minnesota has suspended enrollment in psychiatric drug trials. This comes in response to a blistering report issued by the Minnesota State Legislative Auditor that cites "serious ethical issues" and vindicates much of the reporting in the story below. Read more from Carl Elliott about the fallout from the report here.IT'S NOT EASY TO WORK UP a good feeling about the institution that destroyed your life, which may be why Mary Weiss i...
Source: PharmaGossip - April 3, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Wine anyone?
(Source: PharmaGossip)
Source: PharmaGossip - March 6, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
Tattoo
(Source: PharmaGossip)
Source: PharmaGossip - March 6, 2015 Category: Pharmaceuticals Authors: insider Source Type: blogs
